Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation

Transplantation

Volumn 88, Issue 7, 2009, Pages 935-941

  Kennoki, Takafumi ^a   Ishida, Hideki ^a   Yamaguchi, Yutaka ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Iga recurrence; Kidney transplantation; Tonsillectomy; Urine protein excretion

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN; STEROID; TACROLIMUS;

ADULT; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; THERAPY EFFECT; TONSILLECTOMY; URINARY EXCRETION;

ADULT; BIOPSY; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; TONSILLECTOMY;

EID: 73249147316     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b75374     Document Type: Article

References (21)

1. Rasche FM, Schwart A, Keller F. Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 1999; 51: 147.
2. Pozzi C, Andrulli S, del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy. Long term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157.
3. Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact in patients with IgA nephropathy. Am J Kidney Dis 2001; 38: 736.
4. Sato M, Hotta O, Tomioka S, et al. Cohort study of advanced IgA nephropathy. Efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 2003; 93: 137.
5. Couser W, Recurrent glomerulonephritis in the renal allograft: An update of selected areas. Exp Clin Transplant 2005; 3: 283.
6. Ponticelli C, Traversi L, Feliciani A, et al. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001; 60: 1948.
7. Ponticelli C, Traversi L, Banfi G. Renal transplantation in patients with glomerulonephritis. Pediatr Transplant 2004; 8: 334.
8. Soler MJ, Mir M, Rodiguez E, et al. Recurrence of IgA nephropathy and HS purpura after kidney transplantation: Risk factor and graft survival. Transplant Proc 2005; 37: 3705.
9. Locatelli F, Pozzi C, Del Vecchio L, et al. Role of proteinuria reduction in the progression of IgA nephropathy. Ren Fail 2001; 23; 495.
10. Freese P, Svalander C, Norden C, et al. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999; 13: 313.
11. Chauveau D, Droz D. Follow up evaluation of the first patients with IgA nephropathy described in Necker Hospital. Contrib Nephrol 1993; 104: 1.
12. Lv J, Zhang H, Cui Z, et al. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy. Nephrol Dial Transplant 2008; 23: 2268.
13. Dede F, Onec B, Ayli D, et al. Mycophenolate mofetil treatment of crescentic Henoch-Schonlein nephritis with IgA depositions. Scand J Urol Nephrol 2008; 42: 178.
14. Sahin GM, Sahin S, Kantarci G, et al. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies. Nephrology (Carton) 2007; 12: 285.
15. Kawamura T. Treatment of IgA nephropathy: Corticosteroids, tonsillectomy and mycophenolate mofetil [review]. Contrib Nephrol 2007; 157: 37.
16. Xu G, Tu W, Jiang D, et al. Mycophenolate mofetil treatment for IgA nephropathy. Am J Nephrol 2009; 29: 362.
17. Suzuki K, Honda K, Tanabe K, et al. Incidence of latent IgA deposition in renal allograft donors in Japan. Kid Int 2003; 63: 2286.
18. Alexopoulos E. Treatment of primary IgA nephropathy. Kidney Int 2004; 65: 341.
19. Ikee R, Kobayashi S, Saigusa T, et al. Impact of hypertension and hypertension related vascular lesions in IgA nephropathy. Hypertens Res 2006; 29: 15.
20. Rifai A, Schena EP, Motinaro V, et al. Clearance kinetics and fate of macromolecules IgA in patients with IgA nephropathy. Lab Invest 1989; 61: 381.
21. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988; 12: 371.